On the public citation graph
VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma
0 signed · 57 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cncr.21979openalex-snapshot
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
inferredcites →https://doi.org/10.1002/pbc.20516openalex-snapshot
Temozolomide in resistant or relapsed pediatric solid tumors
inferredcites →https://doi.org/10.1002/pbc.20697openalex-snapshot
Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma
inferredcites →https://doi.org/10.1002/pbc.22206openalex-snapshot
Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan‐Kettering experience
inferredcites →https://doi.org/10.1002/pbc.23225openalex-snapshot
Does surgery have a role in the treatment of local relapses of non‐metastatic rhabdomyosarcoma?
inferredcites →https://doi.org/10.1002/pbc.24621openalex-snapshot
Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
inferredcites →https://doi.org/10.1002/pbc.25622openalex-snapshot
Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second‐line chemotherapy
inferredcites →https://doi.org/10.1007/978-1-4612-4380-9_25openalex-snapshot
Nonparametric Estimation from Incomplete Observations
inferredcites →https://doi.org/10.1016/j.jbi.2008.08.010openalex-snapshot
Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
inferredcites →https://doi.org/10.1037/e407432005-001openalex-snapshot
Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995
inferredcites →https://doi.org/10.1038/bjc.1977.1openalex-snapshot
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
inferredcites →https://doi.org/10.1097/mph.0b013e31825802c2openalex-snapshot
Vincristine, Irinotecan, and Temozolomide for Treatment of Relapsed Alveolar Rhabdomyosarcoma
inferredcites →https://doi.org/10.1200/jco.19.00576openalex-snapshot
Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children’s Oncology Group
inferredcites →https://doi.org/10.1200/jco.1995.13.8.2123openalex-snapshot
Biology and therapy of pediatric rhabdomyosarcoma.
inferredcites →https://doi.org/10.1200/jco.1999.17.11.3487openalex-snapshot
Survival After Relapse in Children and Adolescents With Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Study Group
inferredcites →https://doi.org/10.1200/jco.2001.19.15.3463openalex-snapshot
Cyclophosphamide Plus Topotecan in Children With Recurrent or Refractory Solid Tumors: A Pediatric Oncology Group Phase II Study
inferredcites →https://doi.org/10.1200/jco.2004.05.184openalex-snapshot
Efficacy of Topotecan and Cyclophosphamide Given in a Phase II Window Trial in Children With Newly Diagnosed Metastatic Rhabdomyosarcoma: A Children’s Oncology Group Study
inferredcites →https://doi.org/10.1200/jco.2006.07.1720openalex-snapshot
Two Consecutive Phase II Window Trials of Irinotecan Alone or in Combination With Vincristine for the Treatment of Metastatic Rhabdomyosarcoma: The Children's Oncology Group
inferredcites →https://doi.org/10.1200/jco.2010.29.7390openalex-snapshot
Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.10003openalex-snapshot
Randomized phase II trial of bevacizumab and temsirolimus in combination with vinorelbine (V) and cyclophosphamide (C) for first relapse/disease progression of rhabdomyosarcoma (RMS): A report from the Children’s Oncology Group (COG).
inferredcites →https://doi.org/10.1200/jco.2015.63.4048openalex-snapshot
Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4844849openalex-extracted
Identification of Ferroptosis-Inducers Targeting Glutathione Peroxidase 4 from Herbal Compounds Using Comprehensive Computational Approaches
inferred← citeshttps://doi.org/10.1002/cncr.34785openalex-snapshot
Pediatric DDR inhibitor combinations: Are WEE1 there yet?
inferred← citeshttps://doi.org/10.1002/pbc.27652openalex-snapshot
Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)
inferred← citeshttps://doi.org/10.1002/pbc.31477openalex-snapshot
Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma
inferred← citeshttps://doi.org/10.1002/pbc.32046openalex-snapshot
Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors
inferred← citeshttps://doi.org/10.1016/j.abb.2024.110231openalex-snapshot
Computational discovery of novel GPX4 inhibitors from herbal sources as potential ferroptosis inducers in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2021.103457openalex-snapshot
An overview of current results with the vincristine-irinotecan-temozolomide combination with or without bevacizumab in pediatric, adolescence and adult solid tumors
inferred← citeshttps://doi.org/10.1016/j.eucr.2026.103467openalex-snapshot
Paratesticular rhabdomyosarcoma in adolescents: Challenging diagnosis and poor prognosis of a rare entity
inferred← citeshttps://doi.org/10.1016/j.tice.2019.04.002openalex-snapshot
Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model
inferred← citeshttps://doi.org/10.1080/07391102.2022.2039296openalex-snapshot
Identification of dual binding mode of Orthodiffenes towards human topoisomerase-I and α-tubulin: exploring the potential role in anti-cancer activity via in silico study
inferred← citeshttps://doi.org/10.1093/jscr/rjad451openalex-snapshot
Mesenteric embryonal rhabdomyosarcoma in an adolescent: a case report
inferred← citeshttps://doi.org/10.1097/cad.0000000000000860openalex-snapshot
Primary cardiac rhabdomyosarcoma successfully treated with eribulin: a case report
inferred← citeshttps://doi.org/10.1097/mph.0000000000002128openalex-snapshot
Hypoglycemia Due to Acquired Carnitine Deficiency in a Pediatric Patient Receiving Chemotherapy
inferred← citeshttps://doi.org/10.1177/1078155218790798openalex-snapshot
Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience
inferred← citeshttps://doi.org/10.1186/s12887-021-02904-9openalex-snapshot
Clinical features and prognosis of paediatric rhabdomyosarcoma with bone marrow metastasis: a single Centre experiences in China
inferred← citeshttps://doi.org/10.1186/s13046-019-1107-1openalex-snapshot
The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo
inferred← citeshttps://doi.org/10.1186/s13046-024-03197-3openalex-snapshot
Plasma-derived extracellular vesicles miR-335–5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma
inferred← citeshttps://doi.org/10.1200/jco.21.00124openalex-snapshot
Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial
inferred← citeshttps://doi.org/10.1200/jco.21.01631openalex-snapshot
Reasonable Attempt at a Randomized Trial in Relapsed Rhabdomyosarcoma
inferred← citeshttps://doi.org/10.1200/po.20.00438openalex-snapshot
Clinical Utility of Functional Precision Medicine in the Management of Recurrent/Relapsed Childhood Rhabdomyosarcoma
inferred← citeshttps://doi.org/10.21203/rs.3.rs-51132/v1openalex-snapshot
Risk Factors for Disease Progression and Prognosis Analysis in Pediatric Head and Neck Rhabdomyosarcoma Patients: a Historical Cohort Study From a Single Center
inferred← citeshttps://doi.org/10.2147/cmar.s258689openalex-snapshot
The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study
inferred← citeshttps://doi.org/10.2147/ijwh.s352143openalex-snapshot
Rhabdomyosarcoma in Adults: Case Series and Literature Review
inferred← citeshttps://doi.org/10.2147/ott.s193363openalex-snapshot
Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects
inferred← citeshttps://doi.org/10.3389/fonc.2020.01228openalex-snapshot
A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas
inferred← citeshttps://doi.org/10.3389/fonc.2022.804310openalex-snapshot
Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
inferred← citeshttps://doi.org/10.3390/cancers15215269openalex-snapshot
Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies
inferred← citeshttps://doi.org/10.3390/cancers16051012openalex-snapshot
The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma
inferred← citeshttps://doi.org/10.3390/ijms19092745openalex-snapshot
Molecular Mechanisms Involved in Oxidative Stress-Associated Liver Injury Induced by Chinese Herbal Medicine: An Experimental Evidence-Based Literature Review and Network Pharmacology Study
inferred← citeshttps://doi.org/10.3390/ijms222212299openalex-snapshot
Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines
inferred← citeshttps://doi.org/10.3390/ijms24010856openalex-snapshot
Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression
inferred← citeshttps://doi.org/10.3390/plants9020132openalex-snapshot
Transgenesis as a Tool for the Efficient Production of Selected Secondary Metabolites from Plant in Vitro Cultures
inferred← citeshttps://doi.org/10.3889/oamjms.2019.610openalex-snapshot
Low-Grade Malignancy Glomus Tumor in a Setting of Multiple Glomus Tumors – Case Report
inferred← citeshttps://doi.org/10.4143/crt.2021.178openalex-snapshot
Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults
inferred← citeshttps://doi.org/10.5435/jaaos-d-21-00944openalex-snapshot
Musculoskeletal Metastasis From Soft-tissue Sarcomas: A Review of the Literature
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.